Clinicians treating patients with bipolar disorders and attention-deficit hyperactivity disorder (ADHD) are more likely to identify bupropion as their treatment of choice than other antidepressants

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1545, 2006-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Attention-Deficit Hyperactivity Disorder (ADHD) Treatment and Sudden Death

By Besag Frank M.C.  

Drug Safety, Vol. 32, Iss. 11, 2009-11 ,pp. : 1097-1100

Adis International

Access to resources Recommend Favorite

Important to identify and treat sleep problems in children with attention-deficit hyperactivity disorder (ADHD)

By  

Drugs & Therapy Perspectives, Vol. 27, Iss. 5, 2011-05 ,pp. : 15-17

Adis International

Access to resources Recommend Favorite

‘Pay attention’ to stimulants in attention-deficit hyperactivity disorder when other psychiatric disorders exist

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 20, Iss. 8, 2004-08 ,pp. : 12-15

Adis International

Access to resources Recommend Favorite

The pharmacological treatment of attention-deficit hyperactivity disorder (ADHD) in adolescents is effective and relatively safe

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 11, 2007-11 ,pp. : 9-12

Adis International

Access to resources Recommend Favorite

Modafinil: A Treatment Alternative for Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

By  

Child and Adolescent Psychopharmacology News, Vol. 7, Iss. 6, 2002-12 ,pp. : 5-7

Guilford Publications Inc

Access to resources Recommend Favorite